LIFECORE BIOMEDICAL, INC. Interest Expense
LIFECORE BIOMEDICAL, INC. (LFCR) reported Interest Expense of $17.65 million for the 12-month period ending 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-03-20
- LIFECORE BIOMEDICAL, INC. interest expense for the quarter ending 2023-05-28 was $3.93M, a 135.01% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. interest expense for the quarter ending 2023-02-26 was $4.86M, a 32.07% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. interest expense for the quarter ending 2022-11-27 was $3.62M, a 30.97% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. interest expense for the quarter ending 2022-08-28 was $3.25M, a 47.05% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. interest expense for fiscal 2023 was $17.65M, a 13.49% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. interest expense for fiscal 2022 was $15.55M, a 74.08% increase from fiscal 2021.
- LIFECORE BIOMEDICAL, INC. interest expense for fiscal 2021 was $8.93M, a 92.27% increase from fiscal 2020.
- LIFECORE BIOMEDICAL, INC. interest expense for fiscal 2020 was $4.65M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-05-28 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $8.79M derived: sum of 2 quarters · filed 2024-03-20 | $12.41M derived: sum of 3 quarters · filed 2024-03-20 | $17.65M 10-K · filed 2024-03-20 | ||||
| 2023-02-26 | $4.86M 10-K · filed 2024-03-20 | $5.82M 10-Q · filed 2023-06-02 | $8.48M derived: sum of 2 quarters · filed 2024-03-20 | $13.71M 10-Q · filed 2023-06-02 | $13.40M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2022-11-27 | $3.62M 10-K · filed 2024-03-20 | $4.22M 10-Q · filed 2023-03-16 | $6.87M 10-K · filed 2024-03-20 | $7.90M 10-Q · filed 2023-03-16 | $8.54M derived: sum of 3 quarters · filed 2024-03-20 | $12.22M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2022-08-28 | $3.25M 10-K · filed 2024-03-20 | $3.68M 10-Q · filed 2022-10-07 | $4.92M derived: sum of 2 quarters · filed 2024-03-20 | $8.60M derived: sum of 3 quarters · filed 2024-03-20 | $11.36M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2022-05-29 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $5.35M derived: sum of 2 quarters · filed 2024-03-20 | $8.12M derived: sum of 3 quarters · filed 2024-03-20 | $15.55M 10-K · filed 2024-03-20 | $17.36M 10-K · filed 2022-09-14 | |||
| 2022-02-27 | $3.68M 10-K · filed 2024-03-20 | $4.11M 10-Q · filed 2022-04-07 | $6.44M derived: sum of 2 quarters · filed 2024-03-20 | $13.88M 10-Q · filed 2023-06-02 | $14.90M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-11-28 | $2.77M 10-K · filed 2024-03-20 | $4.33M 10-Q · filed 2022-01-07 | $9.77M 10-Q · filed 2023-03-16 | $12.25M 10-Q · filed 2022-01-07 | $11.22M derived: sum of 3 quarters · filed 2024-03-20 | $13.78M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2021-08-29 | $6.13M 10-K · filed 2024-03-20 | $7.92M 10-Q · filed 2021-10-05 | $8.45M derived: sum of 2 quarters · filed 2024-03-20 | $11.02M derived: sum of 3 quarters · filed 2024-03-20 | $12.61M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-05-30 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $4.89M derived: sum of 2 quarters · filed 2024-03-20 | $6.48M derived: sum of 3 quarters · filed 2024-03-20 | $8.93M 10-K · filed 2024-03-20 | $10.39M 10-K · filed 2022-09-14 | |||
| 2021-02-28 | $2.56M 10-K · filed 2024-03-20 | $4.18M 10-Q · filed 2021-04-08 | $4.16M derived: sum of 2 quarters · filed 2024-03-20 | $6.61M 10-Q · filed 2022-04-07 | $10.33M 10-Q · filed 2021-04-08 | $4.01M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2020-11-29 | $1.60M 10-K · filed 2024-03-20 | $3.04M 10-Q · filed 2021-01-07 | $6.15M 10-Q · filed 2022-01-07 | $1.45M derived: sum of 3 quarters · filed 2024-03-20 | $3.66M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-08-30 | $1.67M 10-K · filed 2024-03-20 | $3.11M 10-Q · filed 2020-10-07 | -$144.00K derived: sum of 2 quarters · filed 2024-03-20 | $2.07M derived: sum of 3 quarters · filed 2024-03-20 | $4.24M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-05-31 | -$1.81M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $402.00K derived: sum of 2 quarters · filed 2023-03-16 | $2.57M derived: sum of 3 quarters · filed 2023-03-16 | $4.65M 10-K/A · filed 2023-03-16 | ||||
| 2020-02-23 | $2.21M 10-Q · filed 2021-04-08 | $4.38M derived: sum of 2 quarters · filed 2021-04-08 | $6.46M 10-Q · filed 2021-04-08 | |||||
| 2019-11-24 | $2.17M 10-Q · filed 2021-01-07 | $4.24M 10-Q · filed 2021-01-07 | ||||||
| 2019-08-25 | $2.08M 10-Q · filed 2020-10-07 | |||||||
| 2019-02-24 | $1.77M 10-Q · filed 2020-04-03 | $3.27M 10-Q · filed 2020-04-03 | ||||||
| 2016-08-28 | $653.00K 10-Q · filed 2016-09-29 | $1.22M derived: sum of 2 quarters · filed 2016-09-29 | $1.70M derived: sum of 3 quarters · filed 2016-09-29 | $2.14M derived: sum of 4 quarters · filed 2016-09-29 | ||||
| 2016-05-29 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $1.05M derived: sum of 2 quarters · filed 2016-08-01 | $1.49M derived: sum of 3 quarters · filed 2016-08-01 | $1.99M 10-K · filed 2016-08-01 | ||||
| 2016-02-28 | $484.00K 10-Q · filed 2016-03-30 | $923.00K derived: sum of 2 quarters · filed 2016-03-30 | $1.43M 10-Q · filed 2016-03-30 | $1.89M derived: sum of 4 quarters · filed 2016-09-29 | ||||
| 2015-11-29 | $439.00K 10-Q · filed 2016-01-07 | $941.00K 10-Q · filed 2016-01-07 | $1.41M derived: sum of 3 quarters · filed 2016-09-29 | $1.92M derived: sum of 4 quarters · filed 2016-09-29 | ||||
| 2015-08-30 | $502.00K 10-Q · filed 2016-09-29 | $966.00K derived: sum of 2 quarters · filed 2016-09-29 | $1.48M derived: sum of 3 quarters · filed 2016-09-29 | $1.95M derived: sum of 4 quarters · filed 2016-09-29 | ||||
| 2015-05-31 | $464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $974.00K derived: sum of 2 quarters · filed 2016-08-01 | $1.45M derived: sum of 3 quarters · filed 2016-08-01 | $1.83M 10-K · filed 2016-08-01 | ||||
| 2015-03-01 | $510.00K 10-Q · filed 2016-03-30 | $982.00K derived: sum of 2 quarters · filed 2016-03-30 | $1.36M 10-Q · filed 2016-03-30 | $1.76M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2014-11-30 | $472.00K 10-Q · filed 2016-01-07 | $855.00K 10-Q · filed 2016-01-07 | $1.25M derived: sum of 3 quarters · filed 2016-08-01 | $1.64M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2014-08-31 | $383.00K 10-Q · filed 2015-10-01 | $776.00K derived: sum of 2 quarters · filed 2016-08-01 | $1.17M derived: sum of 3 quarters · filed 2016-08-01 | $1.60M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2014-05-25 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $783.00K derived: sum of 2 quarters · filed 2016-08-01 | $1.22M derived: sum of 3 quarters · filed 2016-08-01 | $1.65M 10-K · filed 2016-08-01 | ||||
| 2014-02-23 | $390.00K 10-Q · filed 2015-04-02 | $826.00K derived: sum of 2 quarters · filed 2015-04-02 | $1.26M 10-Q · filed 2015-04-02 | $1.74M derived: sum of 4 quarters · filed 2015-04-02 | ||||
| 2013-11-24 | $436.00K 10-Q · filed 2015-01-09 | $867.00K 10-Q · filed 2015-01-09 | $1.35M derived: sum of 3 quarters · filed 2015-01-09 | |||||
| 2013-08-25 | $431.00K 10-Q · filed 2014-10-08 | $913.00K derived: sum of 2 quarters · filed 2014-10-08 | ||||||
| 2013-05-28 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $2.01M 10-K · filed 2014-08-01 | ||||||
| 2013-05-26 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $969.00K derived: sum of 2 quarters · filed 2015-07-31 | $1.47M derived: sum of 3 quarters · filed 2015-07-31 | $2.01M 10-K · filed 2015-07-31 | ||||
| 2013-02-24 | $487.00K 10-Q · filed 2014-03-28 | $985.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.53M 10-Q · filed 2014-03-28 | $1.96M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-11-25 | $498.00K 10-Q · filed 2014-01-03 | $1.04M 10-Q · filed 2014-01-03 | $1.48M derived: sum of 3 quarters · filed 2014-08-01 | $1.63M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-08-26 | $541.00K 10-Q · filed 2013-09-26 | $978.00K derived: sum of 2 quarters · filed 2014-08-01 | $1.13M derived: sum of 3 quarters · filed 2014-08-01 | $1.29M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-05-27 | $437.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $590.00K derived: sum of 2 quarters · filed 2014-08-01 | $753.00K derived: sum of 3 quarters · filed 2014-08-01 | $929.00K 10-K · filed 2014-08-01 | ||||
| 2012-02-26 | $153.00K 10-Q · filed 2013-04-04 | $316.00K derived: sum of 2 quarters · filed 2013-04-04 | $492.00K 10-Q · filed 2013-04-04 | $681.00K derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-11-27 | $163.00K 10-Q · filed 2013-01-04 | $340.00K 10-Q · filed 2013-01-04 | $528.00K derived: sum of 3 quarters · filed 2013-08-07 | $724.00K derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-08-28 | $176.00K 10-Q/A · filed 2013-01-02 | $365.00K derived: sum of 2 quarters · filed 2013-08-07 | $561.00K derived: sum of 3 quarters · filed 2013-08-07 | $770.00K derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-05-29 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $385.00K derived: sum of 2 quarters · filed 2013-08-07 | $594.00K derived: sum of 3 quarters · filed 2013-08-07 | $820.00K 10-K · filed 2013-08-07 | ||||
| 2011-02-27 | $196.00K 10-Q · filed 2012-03-28 | $405.00K derived: sum of 2 quarters · filed 2012-03-28 | $631.00K 10-Q · filed 2012-03-28 | |||||
| 2010-11-28 | $209.00K 10-Q · filed 2012-01-05 | $435.00K 10-Q · filed 2012-01-05 | ||||||
| 2010-08-29 | $227.00K 10-Q · filed 2011-10-05 | |||||||
| 2010-05-30 | $88.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |